Reports
Reports
Sale
The global ambulatory cardiac monitoring devices market size was valued at USD 9.79 billion in 2023, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 to achieve a value of USD 20.92 billion by 2032.
Ambulatory electrical monitors are used to record the electrical activity in the heart over a long period. These devices are wearable and convenient, allowing the patient to wear them easily. They can be worn for days, weeks, or even years. They can be used to diagnose problems that may happen unpredictably even if the patient is not under the supervision of a healthcare professional.
Ambulatory monitors can diagnose arrhythmias, which are irregular heart rhythms. Some common types of arrhythmias include bradyarrhythmias, tachyarrhythmias, supraventricular arrhythmias, and ventricular arrhythmias.
The growth of the global market for ambulatory cardiac monitoring devices is majorly driven by the rising geriatric population, which is both an opportunity and a challenge. The rising cardiovascular disorders across the globe are also driving the market growth. The rise in cardiovascular disorder cases and the increasing geriatric population are majorly contributing to the increasing demand for ambulatory cardiac monitoring devices in the market.
The increasing technological advancements are also gaining traction from healthcare professionals and facilities that are interested in providing the best services to the patient when it comes to cardiac care. Such developments are rapidly aiding the global ambulatory cardiac monitoring devices market growth. The integration of advanced technologies, such as artificial intelligence and machine learning in the healthcare sector, such as ambulatory monitoring devices, greatly influence the market growth as this integration brings clinical confidence and increases efficiency.
The increasing technological development in the market resulting from the increased number of clinical studies to improve the functionality of existing monitoring devices or developing new ones from scratch is a major trend intensifying the market growth. For example, the use of Philips MCOT (Mobile Cardiac Outpatient Telemetry) solutions, based on prescriptions, may result in less expenditure and better patient outcomes by monitoring for arrhythmic disturbances and promoting timely interventions, propelling the market growth. The introduction of smart devices with the integration of advanced technologies, such as machine learning and artificial intelligence, are also driving the growth of the global ambulatory cardiac monitoring devices market.
The increasing number of clinical trials to develop new devices and technologies for better results are also expected to drive the market growth in the coming years.
Market Breakup by Type
Market Breakup by End User
Market Breakup by Region
The growth of the global market is driven by the increasing geriatric population as older people are more susceptible to health conditions, such as high blood pressure, heart failure, diabetes, and thyroid disease, that may lead to arrhythmias. Arrhythmias caused by congenital heart defects or inherited conditions are common in children and young adults.
Key players in the market and governments are greatly investing in research and development activities associated with the development of newly advanced ambulatory cardiac monitoring devices to improve results and patient experiences, which is further driving the global ambulatory cardiac monitoring devices market growth. The presence of robust reimbursement and regulatory policies in developed and emerging economies is expected to directly contribute to the growth of the market during the forecast period. Studies say that nearly 80% of premature heart attacks and strokes are preventable if diagnosed timely. The increasing number of research and clinical studies to overcome the increasing prevalence of cardiovascular diseases and disorders are driving the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ambulatory Cardiac Monitoring Devices Market Overview
3.1 Global Ambulatory Cardiac Monitoring Devices Market Historical Value (2017-2023)
3.2 Global Ambulatory Cardiac Monitoring Devices Market Forecast Value (2024-2032)
4 Global Ambulatory Cardiac Monitoring Devices Market Landscape
4.1 Global Ambulatory Cardiac Monitoring Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ambulatory Cardiac Monitoring Devices Product Landscape
4.2.1 Analysis by Type
5 Global Ambulatory Cardiac Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ambulatory Cardiac Monitoring Devices Market Segmentation
6.1 Global Ambulatory Cardiac Monitoring Devices Market by Type
6.1.1 Market Overview
6.1.2 ECG Devices
6.1.2.1 Resting ECG Devices
6.1.2.2 Stress ECG Devices
6.1.3 Holter Monitors
6.1.4 Event Monitors
6.1.5 Implantable Loop Recorders
6.1.6 Mobile Cardiac Telemetry
6.2 Global Ambulatory Cardiac Monitoring Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Clinics
6.2.3 Ambulatory Care Centers
6.2.4 Others
6.3 Global Ambulatory Cardiac Monitoring Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Ambulatory Cardiac Monitoring Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ambulatory Cardiac Monitoring Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ambulatory Cardiac Monitoring Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ambulatory Cardiac Monitoring Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ambulatory Cardiac Monitoring Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GE Healthcare
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hill-Rom Holdings
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Koninklijke Philips N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medtronic
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nihon Kohden Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Asahi Kasei Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BIOTRONIK SE & Co KG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 BPL Medical Technologies
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iRhythm Technologies, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Ambulatory Cardiac Monitoring Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 9.79 billion in 2023, driven by the increasing research and development.
The market is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032, likely to reach a market value of USD 20.92 billion by 2032.
The increasing prevalence of cardiovascular disorders, rising technological advancements in the healthcare sector, and the advancing healthcare infrastructure are aiding the growth of the market.
The increasing technological development with the integration of advanced technologies in ambulatory cardiac monitoring devices is a major trend influencing the market growth.
There are ECG devices such as resting ECG devices and stress ECG devices. Other devices include holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry.
End users in the market include ambulatory care centers, hospitals and clinics, among others.
Key players involved in the market are Abbott, Boston Scientific Corporation, GE Healthcare, Cardinal Health, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, Asahi Kasei Corporation, BIOTRONIK SE & Co KG, iRhythm Technologies, Inc., and BPL Medical Technologies.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.